Perceived barriers to early diagnosis of breast Cancer in south and southwestern Ethiopia: a qualitative study.
Barriers
Breast cancer
Early diagnosis
Ethiopia
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
27 02 2020
27 02 2020
Historique:
received:
24
07
2019
accepted:
19
02
2020
entrez:
28
2
2020
pubmed:
28
2
2020
medline:
25
8
2020
Statut:
epublish
Résumé
Early diagnosis is a key determinant of breast cancer prognosis and survival. More than half of breast cancer cases are diagnosed at an advanced stage in Ethiopia, and the barriers to early diagnosis in this country are not well understood. We aimed to identify the perceived barriers to early diagnosis of breast cancer from the perspective of patients and health care providers in south and southwestern Ethiopia. A qualitative study was conducted from March to April 2018 using in-depth interviews of breast cancer patients and breast cancer health care providers from six public hospitals located in urban and rural areas of south and southwestern Ethiopia. All participants provided verbal consent before participating. A thematic analysis was performed using Open Code 4.02. Twelve breast cancer patients and thirteen health care providers were included in the study. Patient and health-system related barriers to early diagnosis of breast cancer were identified. Patient-related barriers were lack of knowledge and awareness of breast cancer, belief in traditional medicine and religious practices for treatment, and lack of social and financial support to seek care at a medical facility. Health-system related barriers were misdiagnosis of breast cancer, long distance to referral facilities, high cost of diagnostic services, long waiting time for diagnostic tests, and lack of screening and diagnostic tests in local facilities. Early diagnosis of breast cancer is affected by multiple barriers in south and southwestern Ethiopia. Awareness campaigns and education about the disease, prevention, and early detection are needed to increase early diagnosis of breast cancer. Opportunities exist to improve early diagnosis and timely treatment in rural areas.
Sections du résumé
BACKGROUND
Early diagnosis is a key determinant of breast cancer prognosis and survival. More than half of breast cancer cases are diagnosed at an advanced stage in Ethiopia, and the barriers to early diagnosis in this country are not well understood. We aimed to identify the perceived barriers to early diagnosis of breast cancer from the perspective of patients and health care providers in south and southwestern Ethiopia.
METHODS
A qualitative study was conducted from March to April 2018 using in-depth interviews of breast cancer patients and breast cancer health care providers from six public hospitals located in urban and rural areas of south and southwestern Ethiopia. All participants provided verbal consent before participating. A thematic analysis was performed using Open Code 4.02.
RESULTS
Twelve breast cancer patients and thirteen health care providers were included in the study. Patient and health-system related barriers to early diagnosis of breast cancer were identified. Patient-related barriers were lack of knowledge and awareness of breast cancer, belief in traditional medicine and religious practices for treatment, and lack of social and financial support to seek care at a medical facility. Health-system related barriers were misdiagnosis of breast cancer, long distance to referral facilities, high cost of diagnostic services, long waiting time for diagnostic tests, and lack of screening and diagnostic tests in local facilities.
CONCLUSIONS
Early diagnosis of breast cancer is affected by multiple barriers in south and southwestern Ethiopia. Awareness campaigns and education about the disease, prevention, and early detection are needed to increase early diagnosis of breast cancer. Opportunities exist to improve early diagnosis and timely treatment in rural areas.
Identifiants
pubmed: 32103774
doi: 10.1186/s12905-020-00909-7
pii: 10.1186/s12905-020-00909-7
pmc: PMC7045514
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
38Références
PLoS One. 2017 Feb 13;12(2):e0171024
pubmed: 28192444
J Glob Oncol. 2018 Sep;4:1-11
pubmed: 30241262
Glob Public Health. 2015;10(3):331-44
pubmed: 25443995
Psychooncology. 2011 May;20(5):532-7
pubmed: 21456061
Breast. 2018 Dec;42:23-30
pubmed: 30149234
Patient Educ Couns. 2017 Jan;100(1):167-173
pubmed: 27528411
Cancer. 2008 Oct 15;113(8 Suppl):2244-56
pubmed: 18837017
Cien Saude Colet. 2015 Oct;20(10):3177-89
pubmed: 26465859
J Gen Intern Med. 2016 Oct;31(10):1222-36
pubmed: 27220499
PLoS One. 2018 Nov 29;13(11):e0207928
pubmed: 30496219
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Cancer Causes Control. 2017 Jul;28(7):685-697
pubmed: 28447308
World J Clin Oncol. 2014 Aug 10;5(3):465-77
pubmed: 25114860
Eur J Public Health. 2014 Oct;24(5):761-7
pubmed: 24029456
Breast Care (Basel). 2018 Mar;13(1):39-43
pubmed: 29950966
Rev Esc Enferm USP. 2014 Jun;48(3):394-400
pubmed: 25076265
Lancet Glob Health. 2016 Dec;4(12):e923-e935
pubmed: 27855871
Oncologist. 2015 Jul;20(7):780-8
pubmed: 26032138
Int J Womens Health. 2010 Aug 09;2:77-82
pubmed: 21072300
Int J Cancer. 2014 Nov 1;135(9):2173-82
pubmed: 24658866
Int J Cancer. 2014 Aug 1;135(3):702-9
pubmed: 24375396
Glob Public Health. 2011;6(7):719-31
pubmed: 20865612